Tag: Parkinson’s disease
Biogen-Denali Parkinson’s Drug Fails Phase 2 Trial, Highlighting Treatment Development Challenges
Biogen and Denali's experimental Parkinson's therapy failed Phase 2 trial endpoints, highlighting ongoing challenges in neurodegenerative disease drug development. The…
Gut Microbiome Changes Precede Brain Symptoms in Parkinson’s Disease, Global Analysis Reveals
Global metagenomic analysis reveals that critical gut microbiome changes precede brain symptoms in Parkinson's disease. Two common microbial compounds systematically…
Submit Your Paper to GMJ
No APC until January 2027.